跳至主要内容
临床试验/KCT0008560
KCT0008560招募中Unknown

Biatrial catheter ablation versus Pulmonary vein isolation alone for patients with persistent atrial fibrillation: a randomized controlled trial

Asan Medical Center0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18(Year) 至 85(Year)(—)
性别
All

入选标准

  • Adults between the ages of 18 and 85
  • Diagnosis of persistent atrial fibrillation, which is confirmed by 12-lead electrocardiogram or Holter monitoring lasting for more than 7 days, event recorder, or exercise stress test
  • Resistance or intolerance to at least one class I or III antiarrhythmic drug
  • Patients undergoing the first eablation procedure for atrial fibrillation
  • Patients who have provided informed consent to participate in the study.

排除标准

  • Patients who refuse to participate in the study
  • Patients under 18 or over 85 years of age
  • Left atrial diameter of 60mm or greater
  • Atrial thrombus
  • Contraindication to anticoagulation therapy
  • Previous surgical or procedural treatment for atrial fibrillation
  • Severe valvular heart disease, mitral stenosis, or mechanical prosthetic valve
  • Left atrial diameter of 60mm or greater
  • NYHA class IV heart failure
  • Recent thoracic surgery within the past 3 months
  • Scheduled thoracic surgery within the next 3 months
  • Pulmonary veins observed on CT that are anatomically unsuitable for the procedure
  • End-stage or severe heart failure (estimated glomerular filtration rate [MDRD method] < 30mL/min/1.73m)
  • Pregnant or breastfeeding women
  • NYHA class IV heart failure
  • Acute coronary syndrome within the past 3 months
  • Patients with a life expectancy of less than 1 year.

研究者

相似试验